Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Erhardt

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
European Journal of Heart Failure|August 21, 2001
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practiceJ McMurray, A Cohen-Solal, R Dietz, et al.
Circulation|January 11, 2000
Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) InvestigatorsP Théroux, B R Chaitman, N Danchin, et al.
European Heart Journal|September 1, 1996
Mode of death in chronic heart failure. A request and proposition for more accurate classificationR Narang, J G Cleland, L Erhardt, et al.
International Journal of Clinical Practice|August 12, 2008
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profileJ S Benner, L Erhardt, M Flammer, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
European Journal of Heart Failure|August 21, 2001
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practiceJ McMurray, A Cohen-Solal, R Dietz, et al.
Circulation|January 11, 2000
Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) InvestigatorsP Théroux, B R Chaitman, N Danchin, et al.
European Heart Journal|September 1, 1996
Mode of death in chronic heart failure. A request and proposition for more accurate classificationR Narang, J G Cleland, L Erhardt, et al.
International Journal of Clinical Practice|August 12, 2008
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profileJ S Benner, L Erhardt, M Flammer, et al.
Pageof 11